Nov 02, 2023 / 08:30PM GMT
Operator
Greetings, and welcome to the Vaxart Business Update and Third Quarter 2023 financial results conference call. A question and answer session will follow management's opening remarks. Individual investors may submit written questions to IR at Vaxart.com. As a reminder, this conference is being recorded.
I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President, and General Counsel. Please go ahead Ed.
Edward Berg - Vaxart, Inc. - Senior VP & General Counsel
Good afternoon, and welcome to today's call. Joining us from Vaxart are Andrei Floroiu, Chief Executive Officer, Dr. James Cummings, Chief Medical Officer, Phillip Lee, Chief Financial Officer, and Brant Biehn Senior Vice President for Business Operations.
Before we begin, I would like to remind everyone that during this conference call, Vaxart may make forward-looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations, and its product development and regulatory progress,
Q3 2023 Vaxart Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
